Common TitlePIANO
Official Title A Phase II, Open-label Trial, to Evaluate the Safety, Tolerability and Antiviral Activity of Etravirine (TMC125) in Antiretroviral Experienced HIV-1 Infected Children and Adolescents
Phase Phase II
ClinicalTrials.gov NCT00665847
Treatments
Etravirine
Etravirine
Tradename:IntelenceOther Names:ETRClass:Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)Categories Resistance/Virological FailurePediatricsTreatment-Experienced
Funding
IndustryTibotec Pharmaceuticals
References
- Tambuyzer L, Thys K, Hoogstoel A, et al. Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing: final results of the PIANO study. Antivir Ther. 2016;21:317-27.
- Tudor-Williams G, Cahn P, Chokephaibulkit K, et al. Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Med. 2014;15:513-24.